These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease. Toydemir PB, Elhan AH, Tükün A, Toydemir R, Gürler A, Tüzüner A, Bökesoy I. J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675 [Abstract] [Full Text] [Related]
9. 5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement. Ozkul Y, Evereklioglu C, Borlu M, Taheri S, Calis M, Dündar M, Ilhan O. Br J Ophthalmol; 2005 Dec; 89(12):1634-7. PubMed ID: 16299146 [Abstract] [Full Text] [Related]
10. Factor V Leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behcet's disease. Gurgey A, Balta G, Boyvat A. Blood Coagul Fibrinolysis; 2003 Feb; 14(2):121-4. PubMed ID: 12632020 [Abstract] [Full Text] [Related]
13. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis. Eroglu A, Egin Y, Cam R, Akar N. Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947 [Abstract] [Full Text] [Related]
15. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N. J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606 [Abstract] [Full Text] [Related]